MR Characterization of Focal Nodular Hyperplasia: Gadoxetic Acid versus Superparamagnetic Iron Oxide Imaging

この論文をさがす

抄録

Purpose: We evaluated the diagnostic efficacy of gadoxetic acid- and superparamagnetic iron oxide (SPIO)-enhanced magnetic resonance (MR) imaging for focal nodular hyperplasia (FNH).<br> Materials and Methods: We retrospectively evaluated 11 patients with 11 FNHs. Both gadoxetic acid- and SPIO-enhanced MR imaging were performed. A 3-dimensional (3D) volumetric interpolated breath-hold examination was used with the gadoxetic acid dynamic study. SPIO-enhanced MR imaging included T2- and T2*-weighted images. We quantitatively and qualitatively compared lesion-specific enhancement of both contrast media.<br> Results: The mean signal-to-noise (S/N) ratio of the FNH lesions differed significantly on pre- and postenhanced imaging of each contrast medium (P<0.05); mean contrast-to-noise (C/N) ratio did not (P>0.05). All observers described all lesions as hyperintense in the arterial phase on gadoxetic acid-enhanced MR imaging and observed the presence of central scar, fibrous septa, and rim most clearly in gadoxetic acid-enhanced hepatobiliary phase images.<br> Conclusion: Gadoxetic acid-enhanced MR imaging was more useful than SPIO-enhanced MR imaging in characterizing FNH.<br>

収録刊行物

参考文献 (41)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ